Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 Ann Intern Med
2 Antimicrob Agents Chemother
3 Clin Infect Dis
2 HIV Med
8 J Acquir Immune Defic Syndr
3 J Med Virol
4 J Virol
2 Lancet Infect Dis
1 Neurology
1 Pediatr Infect Dis J
1 PLoS Comput Biol
1 PLoS Genet
9 PLoS One
3 PLoS Pathog


  1. SCOFIELD D, Weis N, Andersson M, Storgaard M, et al
    Psychosocial, sexual, reproductive and menopausal health in women with and without HIV in a high-income setting.
    AIDS. 2023 Mar 29. doi: 10.1097/QAD.0000000000003555.
    >> Share

  2. GONZALEZ J, Wilson A, Byrd D, Cortes EP, et al
    Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV.
    AIDS. 2023 Mar 29. doi: 10.1097/QAD.0000000000003556.
    >> Share

    Ann Intern Med

  3. HERNAN MA, Del Amo J
    Drug Repurposing and Observational Studies: The Case of Antivirals for the Treatment of COVID-19.
    Ann Intern Med. 2023 Mar 28. doi: 10.7326/M22-3582.
    >> Share

    Antimicrob Agents Chemother

  4. MARZINKE MA, Fogel JM, Wang Z, Piwowar-Manning E, et al
    Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
    Antimicrob Agents Chemother. 2023 Mar 30:e0005323. doi: 10.1128/aac.00053.
    >> Share

  5. TIETJEN I, Schonhofer C, Sciorillo A, Naidu ME, et al
    The Natural Stilbenoid (-)-Hopeaphenol Inhibits HIV Transcription by Targeting Both PKC and NF-kappaB Signaling and Cyclin-Dependent Kinase 9.
    Antimicrob Agents Chemother. 2023 Mar 28:e0160022. doi: 10.1128/aac.01600.
    >> Share

    Clin Infect Dis

  6. PEREZ MOLINA JA, Crespillo-Andujar C, Zamora J, Fernandez-Felix BM, et al
    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Mar 28:ciad177. doi: 10.1093.
    >> Share

  7. ZUGER A
    Home HIV testing.
    Clin Infect Dis. 2023 Mar 28:ciad171. doi: 10.1093.
    >> Share

  8. ABELMAN RA, Nguyen TTJ, Ma Y, Bacchetti P, et al
    Body Composition Changes over the Menopausal Transition in Women With and Without HIV.
    Clin Infect Dis. 2023 Mar 28:ciad165. doi: 10.1093.
    >> Share

    HIV Med

  9. ABD-ELMONIEM KZ, Yeramosu T, Purdy JB, Ouwerkerk R, et al
    The role of HIV as a risk modifier for coronary endothelial function in young adults.
    HIV Med. 2023 Mar 30. doi: 10.1111/hiv.13484.
    >> Share

  10. PALACIO-VIEIRA J, Moreno-Fornes S, Diaz Y, Aceiton J, et al
    Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.
    HIV Med. 2023 Mar 29. doi: 10.1111/hiv.13486.
    >> Share

    J Acquir Immune Defic Syndr

  11. JENNINGS L, Ferraris CM, Castillo-Mancilla JR, Robbins RN, et al
    Comparing predictive ability of two objective adherence measures in a community-based cohort on antiretroviral therapy in South Africa: tenofovir diphosphate concentrations and electronic adherence monitors.
    J Acquir Immune Defic Syndr. 2023 Mar 27. doi: 10.1097/QAI.0000000000003198.
    >> Share

  12. ROSEN JG, Mbizvo MT, Phiri L, Chibuye M, et al
    Depression-mediating pathways from household adversity to antiretroviral therapy non-adherence among children and adolescents living with HIV in Zambia: a structural equation modeling approach.
    J Acquir Immune Defic Syndr. 2023 Mar 27. doi: 10.1097/QAI.0000000000003193.
    >> Share

  13. CAMPBELL CK, Dube K, Sauceda JA, Sevelius JM, et al
    Cash Transfer Apps are a Feasible, Acceptable, and More Equitable Method for Compensating Participants in HIV Research.
    J Acquir Immune Defic Syndr. 2023 Mar 27. doi: 10.1097/QAI.0000000000003199.
    >> Share

  14. GARIMELLA PS, Scherzer R, Kestenbaum BR, Hoofnagle AN, et al
    tubular secretory solute clearance and hiv infection.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003200.
    >> Share

  15. STAMP BF, Powers KA, Horvath KJ, Soberano ZR, et al
    Prediction of Sex and the Potential Use of On-Demand PrEP Among Young Men Who Have Sex With Men in the U.S.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003202.
    >> Share

  16. OKEGBE T, Williams J, Plourde KF, Oliver K, et al
    Impact of COVID-19 on HIV Adolescent Programming in 16 Countries with USAID-supported PEPFAR Programs.
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003201.
    >> Share

  17. BOTTANELLI M, Ceccarelli D, Lolatto R, Galli L, et al
    J Acquir Immune Defic Syndr. 2023 Mar 29. doi: 10.1097/QAI.0000000000003192.
    >> Share

  18. YANG B, Sloot R, Floyd S, Awoniyi D, et al
    How do we reach men? Offering HIV testing in evenings and weekends in the HPTN 071 (PopART) community-based trial in South Africa.
    J Acquir Immune Defic Syndr. 2023 Mar 31. doi: 10.1097/QAI.0000000000003197.
    >> Share

    J Med Virol

  19. SCARPA F, Giovanetti M, Azzena I, Locci C, et al
    Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia.
    J Med Virol. 2023 Mar 31. doi: 10.1002/jmv.28714.
    >> Share

  20. SHIN H, Shin H, Rahmati M, Koyanagi A, et al
    Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: a systematic review and meta-analysis.
    J Med Virol. 2023 Mar 29. doi: 10.1002/jmv.28713.
    >> Share

  21. TRUNFIO M, Pinnetti C, Arsuffi S, Bai F, et al
    The Presence of Resistance-associated Mutations in Reverse Transcriptase Gene is Associated with Cerebrospinal Fluid HIV-1 Escape: a multicentric retrospective analysis.
    J Med Virol. 2023 Mar 26. doi: 10.1002/jmv.28704.
    >> Share

    J Virol

  22. LU Y, Pang W, Zhang MD, Song JH, et al
    A Novel Vpu Adaptive Mutation of HIV-1 Degrades Tetherin in Northern Pig-Tailed Macaques (Macaca leonina) Mainly via the Ubiquitin-Proteasome Pathway and Increases Viral Release.
    J Virol. 2023 Mar 27:e0020023. doi: 10.1128/jvi.00200.
    >> Share

  23. MALLARINO-HAEGER C, Pino M, Viox EG, Pagliuzza A, et al
    HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy.
    J Virol. 2023 Mar 27:e0167022. doi: 10.1128/jvi.01670.
    >> Share

  24. STAMOS JD, Rahman MA, Gorini G, Silva de Castro I, et al
    Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or beta-Sheet Conformations on Time of SIV(mac251) Acquisition.
    J Virol. 2023 Mar 28:e0186422. doi: 10.1128/jvi.01864.
    >> Share

  25. CHAPPELL DL, Sandhu PK, Wong JP, Bhatt AP, et al
    KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle.
    J Virol. 2023;97:e0176322.
    >> Share

    Lancet Infect Dis

    HIV vaccine trial failure.
    Lancet Infect Dis. 2023;23:410.
    >> Share

  27. CROSS GB, Sari IP, Kityo C, Lu Q, et al
    Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.
    Lancet Infect Dis. 2023 Mar 23:S1473-3099(23)00067.
    >> Share


  28. SCHIESS N, Kulo V, Anand P, Bearden DR, et al
    Consensus Competencies for Post-Graduate Fellowship Training in Global Neurology.
    Neurology. 2023 Mar 30:10.1212/WNL.0000000000207184.
    >> Share

    Pediatr Infect Dis J

  29. DENOEUD-NDAM L, Stecker C, Andifasi P, Mushavi A, et al
    Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic.
    Pediatr Infect Dis J. 2023 Mar 20. doi: 10.1097/INF.0000000000003906.
    >> Share

    PLoS Comput Biol

  30. HARVEY WT, Davies V, Daniels RS, Whittaker L, et al
    A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenotype of influenza A(H3N2) viruses.
    PLoS Comput Biol. 2023;19:e1010885.
    >> Share

    PLoS Genet

  31. MCHENRY ML, Simmons J, Hong H, Malone LL, et al
    Tuberculosis severity associates with variants and eQTLs related to vascular biology and infection-induced inflammation.
    PLoS Genet. 2023;19:e1010387.
    >> Share

    PLoS One

  32. TCHOUNGA BK, Bertine M, Damond F, Ferre VM, et al
    Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa.
    PLoS One. 2023;18:e0283602.
    >> Share

  33. CHEN Y, Lan G, Feng Y, Ruan Y, et al
    Inferring potential non-disclosed men who have sex with men among self-reported heterosexual men with HIV in Southwest China: A genetic network study.
    PLoS One. 2023;18:e0283031.
    >> Share

  34. GOLDENBERG SM, Pearson J, Moreheart S, Nazaroff H, et al
    Prevalence and structural correlates of HIV and STI testing among a community-based cohort of women sex workers in Vancouver Canada.
    PLoS One. 2023;18:e0283729.
    >> Share

  35. HILL M, Smith J, Elimam D, Mustafaa G, et al
    Ending the HIV epidemic PrEP equity recommendations from a rapid ethnographic assessment of multilevel PrEP use determinants among young Black gay and bisexual men in Atlanta, GA.
    PLoS One. 2023;18:e0283764.
    >> Share

  36. DIAYE AN, Herder T, Agardh A
    Finding a safe space for learning and exploration: A qualitative study of recently diagnosed men's experiences of peer support for HIV in Sweden.
    PLoS One. 2023;18:e0283570.
    >> Share

  37. SILUBONDE TM, Smuts CM, Ware LJ, Chidumwa G, et al
    Determinants of anaemia among women of reproductive age in South Africa: A Healthy Life Trajectories Initiative (HeLTI).
    PLoS One. 2023;18:e0283645.
    >> Share

  38. SINHA S, Thukral H, Shareef I, Desai D, et al
    Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
    PLoS One. 2023;18:e0272682.
    >> Share

  39. PANTAZIS N, Paparizos V, Papastamopoulos V, Metallidis S, et al
    Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/muL on ART.
    PLoS One. 2023;18:e0283648.
    >> Share

  40. MAYITO J, Martineau AR, Tiwari D, Nakiyingi L, et al
    Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study.
    PLoS One. 2023;18:e0281559.
    >> Share

    PLoS Pathog

  41. TOCCAFONDI E, Kanja M, Winter F, Lener D, et al
    A snapshot on HIV-1 evolution through the identification of phylogenetic-specific properties of HIV-1 integrases M/O.
    PLoS Pathog. 2023;19:e1011207.
    >> Share

  42. BYRNES SJ, Busman-Sahay K, Angelovich TA, Younger S, et al
    Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
    PLoS Pathog. 2023;19:e1011290.
    >> Share

  43. ROSINSKI JR, Raasch LE, Barros Tiburcio P, Breitbach ME, et al
    Frequent first-trimester pregnancy loss in rhesus macaques infected with African-lineage Zika virus.
    PLoS Pathog. 2023;19:e1011282.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016